Document is current
Any future updates will be listed below
-
Authors
Drozd, Chloé
Curtit, Elsa
Jacquinot, Quentin
Roux, Pauline
Paget-Bailly, Sophie
Gillet, Valérie
Meneveau, Nathalie
Mougin, Fabienne
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04867096 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy
https://doi.org/10.1007/s10549-026-07923-7
-
Funding
Funding for this research was provided by:
Ligue Contre le Cancer , France
Cancéropole Est
Université Marie et Louis Pasteur
- License Information
-
More Information
Article History
Received: 28 October 2025
Accepted: 7 February 2026
First Online: 26 February 2026
Declarations
:
: The authors declare no competing interests.
: The FATSOMCAN study was approved by the Ethics Committee “Comité de Protection des Personnes Ouest III” on 15/09/2020 under the number 2020-A00511-38, and by the National Health Products Safety Agency (N° IDRCB 2020-A00511-38). This study is registered at the National Clinical Trials (NPSGCT02433067) since 30 April 2021.
: All participants were fully informed of the experimental procedures and provided written informed consent. All methods were carried out in accordance with relevant guidelines and regulations. The current study was performed in accordance with the Declaration of Helsinki.
